HB-EGF, probably released via the actions of enzymes a disintegrin and metalloproteinase 17 (ADAM17) [123,124] or cathepsin B [125], induces the transactivation of EGFR, which leads to increased proliferation of epithelial ovarian cancer cells [86]. The gene discussed is ADAM17; the disease is ovarian carcinoma.